Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when Aclaris Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.

Get ACRS alerts

About Jesse

Jesse has spoken on 1 investor event across 1 company, most recently for Aclaris Therapeutics, Inc. on November 16, 2026. Aclaris Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Aclaris Therapeutics, Inc. includes Neal Walker (CEO, Chairman and Board Member), Kevin Balthaser (CFO), Douglas Manion (COO and Board Member) and 5 others.

Jesse on recent calls

“So the output for the Tezipellumab crossing program was important for us. Going into the Phase 1B readouts, we always had the plan that we were going to be looking at EOE.”
Other, Jefferies Global Healthcare Conference ·

Affiliation history

Company network

Leadership on record at Aclaris Therapeutics, Inc.

Recent activity